Stoichiometry of cyclin A-cyclin-dependent kinase 2 inhibition by p21Cip1/Waf1

被引:16
|
作者
Adkins, JN
Lumb, KJ [1 ]
机构
[1] Colorado State Univ, Dept Biochem & Mol Biol, Ft Collins, CO 80523 USA
[2] Colorado State Univ, Dept Chem, Ft Collins, CO 80523 USA
关键词
D O I
10.1021/bi001524e
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Progression through the eukaryotic cell cycle is regulated by phosphorylation, which is catalyzed by cyclin-dependent kinases. Cyclin-dependent kinases are regulated through several mechanisms, including negative regulation by p21 (variously called CAP20, Cip1, Sdi1, and WAF1). It has been proposed that multiple p21 molecules are required to inhibit cyclin-dependent kinases, such that p21 acts as a sensitive buffer of cyclin-dependent kinase activity or as an assembly factor for the complexes formed by the cyclins and cyclin-dependent kinases. Using purified, full-length proteins of known concentration (determined by absorbance) and cyclin A-Cdk2 of known activity (calibrated with staurosporine), we find that a 1:1 molar ratio of p21 to cyclin A-Cdk2 is able to inhibit Cdk2 activity both in the binary cyclin A-Cdk2 complex and in the presence of proliferating cell nuclear antigen (PCNA). Our results indicate that the mechanism of p21 inhibition of cyclin A-Cdk2 does not involve multiple molecules of bound p21.
引用
收藏
页码:13925 / 13930
页数:6
相关论文
共 50 条
  • [1] The cyclin dependent kinase inhibitor p21Cip1/Waf1 is a therapeutic target in high-risk neuroblastoma
    Sorteberg, Agnes Luise
    Halipi, Vesa
    Wickstroem, Malin
    Shirazi Fard, Shahrzad
    FRONTIERS IN ONCOLOGY, 2022, 12
  • [2] The p21Cip1/Waf1 cyclin-dependent kinase inhibitor is required for the activation of the FA-BRCA pathway
    Rego, Meghan A.
    Mauro, Maurizio
    Harney, Julie A.
    Shen, Mae
    Kolling, Frederick W.
    Howlett, Niall G.
    CANCER RESEARCH, 2010, 70
  • [3] The Role of the Cyclin Dependent Kinase Inhibitor p21cip1/waf1 in Targeting Cancer: Molecular Mechanisms and Novel Therapeutics
    Al Bitar, Samar
    Gali-Muhtasib, Hala
    CANCERS, 2019, 11 (10)
  • [4] Loss of the p21Cip1/Waf1 cyclin kinase inhibitor results in propagation of horizontally transferred DNA
    Bergsmedh, A
    Szeles, A
    Spetz, AL
    Holmgren, L
    CANCER RESEARCH, 2002, 62 (02) : 575 - 579
  • [5] Transcriptional regulation of the cyclin-dependent kinase inhibitor, p21CIP1/WAF1, by the chelator, Dp44mT
    Moussa, Rayan S.
    Kovacevic, Zaklina
    Bae, Dong-Hun
    Lane, Darius J. R.
    Richardson, Des R.
    BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS, 2018, 1862 (03): : 761 - 774
  • [6] Cyclin kinase inhibitor p21CIP1/WAF1 limits interstitial cell proliferation following ureteric obstruction
    Hughes, J
    Brown, P
    Shankland, SJ
    AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY, 1999, 277 (06) : F948 - F956
  • [7] The cyclin kinase inhibitor p21CIP1/WAF1 limits glomerular epithelial cell proliferation in experimental glomerulonephritis
    Kim, YG
    Alpers, CE
    Brugarolas, J
    Johnson, RJ
    Couser, WG
    Shankland, SJ
    KIDNEY INTERNATIONAL, 1999, 55 (06) : 2349 - 2361
  • [8] The p21cip1/waf1 cyclin-dependent kinase inhibitor enhances the cytotoxic effect of cisplatin in human ovarian carcinoma cells
    Lincet, H
    Poulain, L
    Remy, JS
    Deslandes, E
    Duigou, F
    Gauduchon, P
    Staedel, C
    CANCER LETTERS, 2000, 161 (01) : 17 - 26
  • [9] p21Cip1/WAF1 mediates cyclin B1 degradation in response to DNA damage
    Gillis, Laura D.
    Leidal, Andrew M.
    Hill, Richard
    Lee, Patrick W. K.
    CELL CYCLE, 2009, 8 (02) : 253 - 256
  • [10] Expressions of p21cip1/Waf1 and cyclin D1 in the condylar cartilage of developmental TMJ
    Jin, Y
    Li, S
    Tipoe, GL
    Suwa, F
    Takemura, A
    Toda, I
    Ike, H
    Fung, YR
    JOURNAL OF DENTAL RESEARCH, 2000, 79 (05) : 1249 - 1249